Association between fatigue, peripheral serotonin, and L-carnitine in hypothyroidism and in chronic fatigue syndrome.
Raij, Tommi, Raij, Kari · Frontiers in endocrinology · 2024 · DOI
Quick Summary
This study examined whether a supplement called L-carnitine could help reduce fatigue by increasing serotonin levels in the blood. Researchers tracked 12 people with ME/CFS and 40 people with hypothyroidism who were experiencing fatigue, measuring their serotonin and fatigue levels before and after taking L-carnitine for 7 weeks. They found that L-carnitine increased serotonin levels significantly and fatigue decreased by about half in both groups, suggesting a possible connection between low serotonin and fatigue.
Why It Matters
For ME/CFS patients, this study offers preliminary evidence of a biological mechanism linking low peripheral serotonin to fatigue and suggests L-carnitine as a potential therapeutic intervention. Understanding biochemical pathways underlying fatigue is critical for developing targeted treatments in conditions where fatigue persists despite standard care, addressing a major unmet clinical need.
Observed Findings
Serum serotonin increased 8-fold in the CFS group following L-carnitine (p=0.002)
Serum serotonin increased 6-fold in the hypothyroidism group following L-carnitine (p<0.001)
Fatigue scores decreased approximately 2-fold in both groups after L-carnitine supplementation
Negative correlation between serotonin and fatigue strengthened after intervention (CFS: rho -0.49 to -0.67; hypothyroidism: rho -0.24 to -0.83)
Both patient populations showed parallel responses to L-carnitine treatment
Inferred Conclusions
Peripheral serotonin deficiency may contribute to fatigue in both ME/CFS and treatment-resistant hypothyroid fatigue
L-carnitine may facilitate serotonin normalization through a yet-unspecified mechanism
Low peripheral serotonin and fatigue severity are inversely correlated, particularly after L-carnitine intervention
These findings suggest a common biological pathway in fatigue across different disease etiologies
Remaining Questions
What is the mechanism by which L-carnitine increases peripheral serotonin levels?
Do these findings hold in a larger, prospective, placebo-controlled trial?
What This Study Does Not Prove
This study does not prove that L-carnitine causes fatigue reduction or that low serotonin causes ME/CFS fatigue—it only shows correlation. The small sample size, absence of a placebo control group, and retrospective design prevent definitive causal conclusions. Results cannot be generalized to the broader ME/CFS population without prospective, randomized controlled trials.
What is the optimal dosage and duration of L-carnitine supplementation, and are effects sustained long-term?
Does peripheral serotonin adequately reflect central nervous system serotonin, and is peripheral measurement clinically relevant to ME/CFS pathophysiology?